These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32919304)

  • 21. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
    Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.
    Yang J; Liao D; Wang Z; Liu F; Wu G
    J Surg Res; 2011 Jun; 168(1):97-102. PubMed ID: 20036387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental validation of 5 in-silico predicted glioma biomarkers.
    Towner RA; Jensen RL; Vaillant B; Colman H; Saunders D; Giles CB; Wren JD
    Neuro Oncol; 2013 Dec; 15(12):1625-34. PubMed ID: 24158112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
    Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
    Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
    Vachher M; Arora K; Burman A; Kumar B
    J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
    Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
    J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Label-free quantitative proteomics unravels the importance of RNA processing in glioma malignancy.
    Bi B; Li F; Guo J; Li C; Jing R; Lv X; Chen X; Wang F; Azadzoi KM; Wang L; Liu Y; Yang JH
    Neuroscience; 2017 May; 351():84-95. PubMed ID: 28341197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
    Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
    Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The overexpression of epithelial cell adhesion molecule (EpCAM) in glioma.
    Chen X; Ma WY; Xu SC; Liang Y; Fu YB; Pang B; Xin T; Fan HT; Zhang R; Luo JG; Kang WQ; Wang M; Pang Q
    J Neurooncol; 2014 Aug; 119(1):39-47. PubMed ID: 24906438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
    Ni W; Xia Y; Luo L; Wen F; Hu D; Bi Y; Qi J
    Cell Biol Int; 2020 Feb; 44(2):569-582. PubMed ID: 31642564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
    Guo SK; Shen MF; Yao HW; Liu YS
    Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
    Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
    J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma.
    Liu H; Li G; Zeng W; Zhang P; Fan F; Tu Y; Zhang Y
    Med Oncol; 2014 Aug; 31(8):77. PubMed ID: 24998422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
    Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
    Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.